US Stock MarketDetailed Quotes

FBLG FibroBiologics

Watchlist
  • 2.360
  • +0.050+2.16%
Close Dec 27 16:00 ET
  • 2.400
  • +0.040+1.69%
Post 20:01 ET
81.80MMarket Cap-4.50P/E (TTM)

About FibroBiologics Company

FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm’s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O’Heeron on April 8, 2021 and is headquartered in Houston, TX.

Company Profile

SymbolFBLG
Company NameFibroBiologics
Listing DateJan 31, 2024
Founded2021
CEOMr. Peter O’Heeron
MarketNASDAQ
Employees10
Fiscal Year Ends12-31
Address455 East Medical Center Boulevard,Suite 300
CityHouston
ProvinceTexas
CountryUnited States of America
Zip Code77598
Phone1-281-671-5150
Websitehttp://www.fibrobiologics.com

Company Executives

  • Name
  • Position
  • Salary
  • Peter O’Heeron
  • Chairperson of the Board and Chief Executive Officer
  • 4.29M
  • Robert E. Hoffman, C.P.A.
  • Director, Interim Chief Financial Officer and Principal Accounting Officer
  • 388.54K
  • Dr. Hamid Khoja, PhD
  • Chief Scientific Officer
  • 1.31M
  • Richard C. Cilento, Jr,M.B.A.
  • Independent Director
  • 376.54K
  • Matthew Link
  • Independent Director
  • 379.54K
  • Dr. Victoria Niklas, M.D.
  • Independent Director
  • 381.54K
  • Stacy Ann Coen, M.B.A.
  • Independent Director
  • 384.54K
  • Ruben A. Garcia
  • General Counsel
  • --
Heat List
US
Overall
Symbol
Price
% Chg

No Data